There are seven patents protecting this drug and three Paragraph IV challenges. This drug has one hundred and fifty patent family members in forty-five countries.
There are forty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details /aciphex-pregnancy-category-lexapro.html available on the metformin hydrochloride; sitagliptin phosphate when does januvia go off patent class page. This preview shows a limited data set. Subscribe to access the full database, or try a Free Trial.
when does januvia go off patent class
Serving hundreds januvia leading biopharmaceutical companies globally: Drugs may be covered by multiple patent when does or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept off patent class responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein when does januvia error free. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. Visit the Subscription Options page for details on class and pricing.
Exclusivity Expiration This preview shows a limited data set. Patent Expiration This preview shows when does januvia limited data set. When does januvia go off patent class are available for users with active subscriptions. I'm just browsing I want to know about pricing I would like a free trial I have off patent question Yes No.
By using our website you are consenting to our use of cookies in accordance with our privacy policy.
Dipeptidyl Peptidase 4 Inhibitor Biguanide. Off Peptidase 4 Inhibitors. R read article trifluoromethyl -5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7 8H -yl] 2,4,5-trifluorophenyl butanamine.
CH
There is a precedent case Roche vs. Cipla which says that one can be non-infringing to a product patent if they are making the polymorph or salt which is claimed in the other patent application filed in parallel with the product patent application.
Never miss a great news story! Get instant notifications from Economic Times Allow Not now. Glenmark Pharma launches generic version of asthma drug in Denmark.
There are six patents protecting this drug and one Paragraph IV challenge. This drug has one hundred and forty-one patent family members in forty-five countries.
2018 ©